콘텐츠로 건너뛰기
Merck
모든 사진(9)

주요 문서

ZRB2246

Sigma-Aldrich

Anti-TIFAB Antibody, clone 1B15 ZooMAb® Rabbit Monoclonal

enhanced validation
greener alternative

recombinant, expressed in HEK 293 cells

동의어(들):

TIFA-like protein, TRAF-interacting protein with FHA domain-containing protein B

로그인조직 및 계약 가격 보기


About This Item

UNSPSC 코드:
12352203
NACRES:
NA.41
결합:
unconjugated
application:
ICC
WB
affinity binding assay
클론:
1B15, recombinant monoclonal
종 반응성:
human
citations:
기술:
affinity binding assay: suitable
immunocytochemistry: suitable
western blot: suitable

생물학적 소스

rabbit

Quality Level

재조합

expressed in HEK 293 cells

결합

unconjugated

항체 형태

purified antibody

항체 생산 유형

primary antibodies

클론

1B15, recombinant monoclonal

설명

1B15 Clone

제품 라인

ZooMAb® learn more

양식

lyophilized

분자량

calculated mol wt 17.89 kDa
observed mol wt ~18 kDa

정제법

using Protein A

종 반응성

human

포장

antibody small pack of 25 μL

환경친화적 대안 제품 특성

Waste Prevention
Designing Safer Chemicals
Design for Energy Efficiency
Learn more about the Principles of Green Chemistry.

향상된 검증

recombinant expression
Learn more about Antibody Enhanced Validation

기술

affinity binding assay: suitable
immunocytochemistry: suitable
western blot: suitable

동형

IgG

에피토프 서열

C-terminal

단백질 ID 수납 번호

UniProt 수납 번호

환경친화적 대안 카테고리

배송 상태

ambient

저장 온도

2-8°C

유전자 정보

human ... TIFAB(497189)

관련 카테고리

일반 설명

We are committed to bringing you greener alternative products, which adhere to one or more of The 12 Principles of Green Chemistry. This antibody is Preservative-free, produced without the harm or sacrifice of animals and exceptionally stable to allow for ambient shipping and storage if needed and thus aligns with "Waste Prevention", "Designing Safer Chemicals" and "Design for Energy Efficiency". Click here for more information.
ZooMAb® antibodies represent an entirely new generation of recombinant monoclonal antibodies. Each ZooMAb® antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb® antibodies are reliably available and ready to ship when you need them.

특이성

Clone 1B15 is a ZooMAb® rabbit recombinant monoclonal antibody that specifically detects TRAF-interacting protein with FHA domain-containing protein B (TIFAB). It targets an epitope within 16 amino acids from the C-terminal region.

면역원

KLH-conjugated linear peptide corresponding to 16 amino acids from the C-terminal region of human TRAF-interacting protein with FHA domain-containing protein B (TIFAB).

애플리케이션

Quality Control Testing

Evaluated by Western Blotting in THP-1 cell lysate.

Western Blotting Analysis: A 1:10,000 dilution of this antibody detected TIFAB in THP-1 cell lysate.

Tested Applications

Immunocytochemistry Analysis: A 1:100 dilution from a representative lot detected TIFAB in THP-1 cells.

Affinity Binding Assay: A representative lot of this antibody bound TIFAB peptide with a KD of 1.4 x 10-6 in an affinity binding assay.

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

표적 설명

TRAF-interacting protein with FHA domain-containing protein B (UniProt: Q6ZNK6;  also known as TIFA-like protein) is encoded by the TIFAB gene (Gene ID: 497189) in human. TRAF-interacting protein with an forkhead-associated (FHA) (TIFA) and TRAF-interacting protein with FHA domain-containing protein B (TIFAB) are important modifiers of the innate immune signaling through their regulation of TRAF proteins.  They contain highly conserved FHA domain that recognizes p-threonine residues on interacting proteins. The FHA domain of TIFAB is localized in amino acids 36-91, which is flanked by short N-and C-terminal sequences. TIFA serves as a positive regulator of innate immune and inflammatory pathways, whereas TIFAB is a negative regulator of innate immune and inflammatory pathways. TIFAB expression is observed in spleen, lung, thymus, and small intestine. It is also enriched in myeloid progenitors and monocytes. It is shown to be highly expressed in the more immature fraction of normal human bone marrow (BM) CD34+ stem/progenitor cells as compared with the mature cell fraction of CD34- BM cells. TIFAB is shown to associate with TIFA and block TIFA-mediated activation of NF-κB, without affecting TIFA levels. The human TIFAB protein displays about 80% homology to mouse TIFAB but contains 14 additional amino acids at its C-terminal end. Deletion of TIFAB in hematopoietic stem and progenitor cells has been linked to bone marrow failure in murine models. Its deletion is reported to increase p53 signaling and reduce leukemic cell function and leukemia development. Conversely, elevated levels of TIFAB represses p53 and increase leukemic progenitor function. This ZooMAb® recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Niederkorn, M., et al. (2020). Exp. Hematol. 90; 18-29; Niederkorn, M., et al. (2020). Cell Rep. 30(8); 2776-2790; Matsumura, T., et al. (2004). Biochem. Biophys. Res. Commun. 317(1); 230-234).

물리적 형태

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. The PBS/trehalose components in the ZooMAb formulation can have the appearance of a semi-solid (bead like gel) after lyophilization. This is a normal phenomenon. Please follow the recommended reconstitution procedure in the data sheet to dissolve the semi-solid, bead-like, gel-appearing material. The resulting antibody solution is completely stable and functional as proven by full functional testing. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.

재구성

300 µg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

저장 및 안정성

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

기타 정보

Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.

법적 정보

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

면책조항

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

적합한 제품을 찾을 수 없으신가요?  

당사의 제품 선택기 도구.을(를) 시도해 보세요.

Storage Class Code

11 - Combustible Solids

WGK

WGK 1

Flash Point (°F)

Not applicable

Flash Point (°C)

Not applicable


가장 최신 버전 중 하나를 선택하세요:

시험 성적서(COA)

Lot/Batch Number

죄송합니다. 지금은 이 제품에 대한 COA이(가) 온라인에서 제공되지 않습니다.

도움이 필요하시면 연락하세요. 고객 지원 부서

이 제품을 이미 가지고 계십니까?

문서 라이브러리에서 최근에 구매한 제품에 대한 문서를 찾아보세요.

문서 라이브러리 방문

자사의 과학자팀은 생명 과학, 재료 과학, 화학 합성, 크로마토그래피, 분석 및 기타 많은 영역을 포함한 모든 과학 분야에 경험이 있습니다..

고객지원팀으로 연락바랍니다.